Search
Bavtavirine
go.drugbank.com/drugs/DB21527InvestigationalBavtavirine is under investigation in clinical trial NCT05585307 (Study of Novel Antiretrovirals in Participants With HIV-1). Bavtavirine has a monoisotopic molecular weight of 416.17 Da. … The usage of the INN stem '-virine' in the name indicates that Bavtavirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Cenacitinib
go.drugbank.com/drugs/DB21735InvestigationalCenacitinib has a monoisotopic molecular weight of 431.15 Da. … The usage of the INN stem '-citinib' in the name indicates that Cenacitinib is a Janus kinase inhibitor.
IL15-NK Cell
go.drugbank.com/drugs/DB15725InvestigationalIn particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor targets that the cell is not normally sensitive to.
Cyamemazine
go.drugbank.com/drugs/DB09000ExperimentalCyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class used primarily in the treatment of schizophrenia and psychosis-associated anxiety. … Cyamemazine actually behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A).
VPM4001
go.drugbank.com/drugs/DB05089ExperimentalVPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. … Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells.
Alofanib
go.drugbank.com/drugs/DB20918InvestigationalAlofanib is under investigation in clinical trial NCT04071184 (Study of Alofanib in Patients With Metastatic Gastric Cancer). Alofanib has a monoisotopic molecular weight of 413.07 Da. … The usage of the INN stem '-anib' in the name indicates that Alofanib is a angiogenesis inhibitor.
Adomeglivant
go.drugbank.com/drugs/DB11704InvestigationalAdomeglivant has been investigated for the basic science of Type 2 Diabetes.
CAM-101
go.drugbank.com/drugs/DB18414InvestigationalCAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
TTX-siPDL1
go.drugbank.com/drugs/DB18550ExperimentalTTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.
Monteplase
go.drugbank.com/drugs/DB12726InvestigationalMonteplase has been used in trials studying the treatment of Pulmonary Embolism.